Search

Your search keyword '"Sionis D"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Sionis D" Remove constraint Author: "Sionis D"
44 results on '"Sionis D"'

Search Results

1. One-Year Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the Greek Antiplatelet Atrial Fibrillation Registry

2. Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention

3. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

4. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

5. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

6. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

7. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

8. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

10. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

11. Multiple organ failure

12. Dual antiplatelet therapy duration after coronary stenting in clinical practice: Results of an EAPCI survey

13. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction

14. One year effectiveness of BiodivYsio dexamethazone-eluting stent compared to BiodivYsio stent implantation in the treatment of single vessel coronary artery disease

15. Antiplatelet is superior to anticoagulant treatment after coronary stenting: Fewer coronary and other events within 30 days after stenting

23. Ventricular extrasystolic arrhythmias in exercise testing II. Haemodynamic correlations.

25. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

26. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

27. One-Year Outcomes in Anticoagulated Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the Greek Antiplatelet Atrial Fibrillation Registry.

28. Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention.

29. The importance of characteristics of angina symptoms for the prediction of coronary artery disease in a cohort of stable patients in the modern era.

30. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.

31. Extent of coronary artery disease in patients undergoing angiography for stable or acute coronary syndromes.

32. Large bronchogenic cyst compressing the left atrium.

33. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.

34. One year effectiveness of BiodivYsio dexamethazone-eluting stent compared to BiodivYsio stent implantation in the treatment of single vessel coronary artery disease.

35. Antiplatelet is superior to anticoagulant treatment after coronary stenting: fewer coronary and other events within 30 days after stenting.

36. Coronary angioplasty in the elderly: immediate and long-term results.

37. Double left anterior descending artery originating from the left and right coronary artery: a rare coronary artery anomaly.

38. Use of an autoperfusion catheter in the treatment of acute refractory vessel closure after coronary balloon angioplasty: immediate and six month follow up results.

40. Coronary hemodynamics and coronary flow reserve after intracoronary diltiazem in humans.

41. Hemodynamic changes after subselective intracoronary administration of nisoldipine in humans.

42. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries.

43. Changes in human coronary flow reserve after administration of intracoronary diltiazem.

44. Early detection of silent ischemia after bypass grafting.

Catalog

Books, media, physical & digital resources